NDC 17312-017 – Asthma Therapy
Strychnos Nux-vomica Seed 6 [hp_C]/1; Aspidosperma Quebracho-blanco Bark 6 [hp_C]/1; Sulfur 6 [hp_C]/1; Arsenic Trioxide 6 [hp_C]/1; Histamine Dihydrochloride… · Tablet, Orally Disintegrating · Oral
Product NDC17312-017
Product details
- Brand name
- Asthma Therapy
- Generic name
- Arsenic Trioxide - Histamine Dihydrochloride - Dermatophagoides Pteronyssinus - Magnesium Phosphate, Dibasic Trihydrate - Strychnos Nux-vomica Seed - Aspidosperma Quebracho-blanco Bark - Suplhur -
- Labeler
- TRP Company
- Dosage form
- Tablet, Orally Disintegrating
- Route
- Oral
- Marketing category
- UNAPPROVED HOMEOPATHIC
- Marketed since
- December 1, 2011
- Listing expires
- December 31, 2026
- Pharmacologic class
- Calculi Dissolution Agent; Non-Standardized Plant Allergenic Extract; Osmotic Laxative; Standardized Insect Allergenic Extract
Active ingredients
- Strychnos Nux-vomica Seed 6 [hp_C]/1
- Aspidosperma Quebracho-blanco Bark 6 [hp_C]/1
- Sulfur 6 [hp_C]/1
- Arsenic Trioxide 6 [hp_C]/1
- Histamine Dihydrochloride 6 [hp_C]/1
- Dermatophagoides Pteronyssinus 6 [hp_C]/1
- Magnesium Phosphate, Dibasic Trihydrate 6 [hp_C]/1
Uses, dosage, side effects and warnings for Asthma Therapy →
Package NDC codes (1)
| Package NDC | Description | Since |
|---|---|---|
| 17312-017-14 | 1 BOTTLE in 1 PACKAGE (17312-017-14) / 70 TABLET, ORALLY DISINTEGRATING in 1 BOTTLE | Oct 30, 2012 |